Join to view full profile
200 Great Valley PkwyMalvern, PA 19355
Phone+1 610-240-8321
Dr. Dawkins is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
George Washington UniversityFellowship, Hematology and Medical Oncology, 1988 - 1991
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1984
Certifications & Licensure
DC State Medical License 1990 - 2018
Clinical Trials
Publications & Presentations
PubMed
- 221 citationsRuxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): A multicenter, open-label phase 2 trialMadan Jagasia, Miguel-Angel Perales, Mark A. Schroeder, Haris Ali, Nirav N. Shah
Blood. 2020-05-14 - 10 citationsPain questionnaire performance in advanced prostate cancer: comparative results from two international clinical trialsDon Robinson, Ning Zhao, Fitzroy Dawkins, Ming Qi, Dennis A. Revicki
Quality of Life Research. 2013-04-16 - 30 citationsScreening for iron overload: Lessons from the HEmochromatosis and IRon Overload Screening (HEIRS) StudyPaul C. Adams, James C. Barton, Gordon D. McLaren, Ronald T. Acton, Mark Speechley
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie. 2009-11-01
Press Mentions
Forma Therapeutics : Appoints Two New Vice Presidents to Lead Key Organizational FunctionsSeptember 15th, 2020
Clinical Manifestations of Hemochromatosis in HFE C282Y Homozygotes Identified by ScreeningJuly 20th, 2019
Grant Support
- HeirsNational Center For Research Resources2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
